Scabies remains one of the commonest of skin diseases seen in developing countries.
Although its distribution is subject to a cycle of infection, with peaks and troughs of disease …

Scabies is an ectoparasite caused by the mite Sarcoptes scabiei var hominis, an obligate
human parasite. There are about 300 million cases of scabies in the world each year …

Ivermectin is increasingly being used to treat scabies, especially crusted (Norwegian)
scabies. However, treatment failures, recrudescence, and reinfection can occur, even after …

Background: Scabies is a neglected skin disease, and little is known about current incidence
and treatment patterns in the United States. The purpose of this study was to examine …

Background Scabies is an ancient disease (documented as far back as 2500 years ago). It
affects about 300 million people annually worldwide, and the prevalence is as high as about …

Globally, scabies affects more than 130 million people at any time. In the developed world,
outbreaks in health institutions and vulnerable communities result in a significant economic …

The impact of the severe drought in Ethiopia, attributed to El Niño weather conditions, has
led to high levels of malnutrition that have, in turn, increased the potential for disease …

Scabies in healthcare settings : Current Opinion in Infectious Diseases Scabies in healthcare
settings : Current Opinion in Infectious Diseases Log in or Register Subscribe to …

Crusted scabies is a rare manifestation of scabies characterized by uncontrolled
proliferation of mites in the skin. In immunocompromised patients, this infestation is …

Ivermectin is a broad-spectrum antiparasitic drug with anti-inflammatory, anti-viral, anti-
bacterial, and anti-tumor effects. In this review, we discuss the history, pharmacology …